Adrian Parry-Jones is an NIHR Clinician Scientist at the University of Manchester and an Honorary Consultant Neurologist at Salford Royal NHS Foundation Trust. He trained in Medicine at the University of Manchester and undertook clinical training in the North West and London. He was awarded an MRC Clinical Research Training Fellowship to undertake his PhD studies investigating the role of brain temperature in interleukin-1 mediated ischaemic brain injury. He completed his training in Neurology and Stroke Medicine in the North West and in Melbourne, Australia and commenced his current NIHR Clinician Scientist Award in March 2015. His current research and clinical work is focused on improving outcomes after intracerebral haemorrhage, a devastating form of stroke with poor outcomes and few treatments. His NIHR award is funding early phase observational studies, clinical trials and multiparametric imaging to understand the therapeutic potential of modulating the inflammatory response to intracerebral haemorrhage.
Where do you see the industry in the next 20 years?
I would personally like to see the growing interest in intracerebral haemorrhage translated in to improved outcomes for this historically neglected group of patients.
Why are you excited about participating in STROKE 2018?
Australasia has been and continues to be a leader in stroke care and research and I look forward to participating in what I’m sure will be an exciting and diverse meeting.